×
Wednesday, December 25, 2024

Proactive news headlines including Elon Musk, Vuzix, Context Therapeutics and American Manganese - Financial Post

Last updated Friday, December 3, 2021 13:17 ET , Source: NewsService

Article content

New York , Dec. 03, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

  • Vuzix signs distribution agreement with Austrian firm, receives initial Smart Glasses order click here
  • Elon Musk sells US$1bn worth of Tesla shares after exercising further options click here
  • Revive Therapeutics expands research with Bucillamine as potential treatment for Omicron variant click here
  • Great Atlantic Resources intersects high-grade quartz veins and visible gold at its Golden Promise project in Newfoundland click here
  • Harbor Custom Development acquires 438-acre master planned community near Vancouver, B.C. for $14M click here
  • LexaGene closes multiple MiQLab sales as it makes good progress in sales cycle click here
  • KetamineOne subsidiary KGK Science helps its client Hofseth Biocare receive New Dietary Ingredient status from US FDA click here
  • American Manganese poised to strengthen its global patent portfolio with latest filing click here
  • Context Therapeutics reports 3Q results during a “pivotal” period for the company click here

Article content

About Proactive

  • Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle.
  • With six offices on three continents, Proactive works with innovative growth companies quoted on the world’s major stock exchanges,...


Read Full Story: https://financialpost.com/globe-newswire/proactive-news-headlines-including-elon-musk-vuzix-context-therapeutics-and-american-manganese

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.